IDEAS home Printed from https://ideas.repec.org/a/prg/jnloce/v13y2020i1-2id2020_1_04p53-64.html
   My bibliography  Save this article

Specifics of valuation in the drug development sector
[Specifika oceňování v sektoru vývoje léčiv]

Author

Listed:
  • Jakub Mašek
  • Radana Šmídová

Abstract

The aim of this article is to analyse specific aspects of valuation in drug development sector. The article is reacting to recent development around SARS-CoV-2 pandemic and aims to provide valuable information to professionals from investment community interested in opportunities in pharma and biotech sector. Consequently article involves deep analysis of the industry, its dynamics and industry specifics that are determining for company valuation.

Suggested Citation

  • Jakub Mašek & Radana Šmídová, 2020. "Specifics of valuation in the drug development sector [Specifika oceňování v sektoru vývoje léčiv]," Oceňování, Prague University of Economics and Business, vol. 13(1-2), pages 53-64.
    • Handle: RePEc:prg:jnloce:v:13:y:2020:i:1-2:id:2020_1_04:p:53-64
    DOI: 10.18267/j.ocenovani.246
    as

    Download full text from publisher

    File URL: http://ocenovani.vse.cz/doi/10.18267/j.ocenovani.246.html
    Download Restriction: free of charge
    File URL: http://ocenovani.vse.cz/doi/10.18267/j.ocenovani.246.pdf
    Download Restriction: free of charge
    File URL: https://libkey.io/10.18267/j.ocenovani.246?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Keywords

    Valuation; Pharmacy; Biotech; Intangible assets; Patent protection; Clinical trials; Oceňování; Farmacie; Práva nehmotného vlastnictví; Patentová ochrana; Klinické testování;
    All these keywords.

    JEL classification:

    • G39 - Financial Economics - - Corporate Finance and Governance - - - Other

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:prg:jnloce:v:13:y:2020:i:1-2:id:2020_1_04:p:53-64. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Stanislav Vojir (email available below). General contact details of provider: https://edirc.repec.org/data/uevsecz.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.